TNFRSF11A and Osteopenia: Still, the therapeutic effects on CVS-induced osteopenia were attributed to reduced osteoclastogenesis, and the CVS-impaired osteoblastic bone formation was not rescued by RANK-Fc and clodronate (Fig. 6c–h).